tiprankstipranks

Analyst Profile

Followed by 1,866 followers
.
Edward White

Edward White

H.C. Wainwright
Wall Street Analyst
#7,883 out of 7,986 Wall Street Analysts
#21,958 out of 22,378 experts

Success Rate

24%
86 out of 356 transactions made a profit

Average Return

-22.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Edward White's trades since 2014 and holding each position for 1 Year would result in 24.16% of your transactions generating a profit, with an average return of -22.3% per rating.

Stock Rating Distribution

1KRatings
92.11% Buy
7.89% Hold
0.00% Sell
Distribution of Edward White's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Dynavax Technologies
(DVAX)
Rating:Buy
Date:Nov 06, 2020 - Nov 06, 2021
Return:+289.30%
The most profitable rating made by Edward White

Edward White's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Phio Pharmaceuticals
Jun 02, 2014
Buy
Initiated
$8.00
(1314.68% Upside)
1Ratings
0.00%
FBRC
FBR & Co
Oct 06, 2015
Buy
Reiterated
1Ratings
0.00%
Relmada Therapeutics
Oct 19, 2016
Hold
Reiterated
6Ratings
0.00%
NantHealth
Mar 31, 2017
Buy
Reiterated
$13.00
(4774.39% Upside)
4Ratings
0.00%
ImmunityBio
Apr 04, 2017
Buy
Reiterated
8Ratings
0.00%
INNL
Innocoll
Apr 05, 2017
Hold
Reiterated
5Ratings
0.00%
Agile Therapeutics
Apr 11, 2017
Buy
Reiterated
10Ratings
0.00%
ARGSQ
Argos Therapeutics
Apr 19, 2017
Hold
Reiterated
13Ratings
0.00%
Fortress Biotech
May 11, 2017
Buy
Reiterated
$11.00
(1121.41% Upside)
15Ratings
0.00%
CORI
Corium
May 11, 2017
Buy
Reiterated
15Ratings
0.00%
List of latest recommendations made by Edward White. Click to expand and see Edward White's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >